AKRX News Alert Akorn Inc (AKRX) 36.47 12/25/2014 05:13:23

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Akorn Inc (AKRX) 36.47 $AKRX

Strength Seen in Parnell (PARN): Stock Moves 5.3% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Dec 24, 8:25AM CST
Parnell (PARN) was a big mover last session, with shares rising over 5% on the day.
PARN: 4.88 (-0.10), AKRX: 36.47 (+0.43)

Actavis' Antibiotic a Step Closer to EU Nod, CHMP Positive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 22, 4:51PM CST
Actavis' (ACT) antibiotic, Xydalba, which is already marketed in the U.S. under the trade name Dalvance, is a step closer to EU approval.
AGN: 210.12 (+0.95), ACT: 254.20 (-1.68), AKRX: 36.47 (+0.43), MYL: 56.97 (+0.39)

Akorn to Present at the 33rd Annual J.P. Morgan Healthcare Conference
GlobeNewswire - Fri Dec 19, 8:30AM CST
Akorn, Inc. (Nasdaq:AKRX), a specialty generic pharmaceutical company, announced today that Raj Rai, Chief Executive Officer, will provide an overview and update of the Company's business at the 33 Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2015 at 4:00 pm PST (7:00 pm EST) at the Westin St. Francis Hotel, San Francisco, California. Mr. Rai's presentation to investors will be webcast and available to interested investors and analysts.
JPM: 62.48 (unch), AKRX: 36.47 (+0.43)

AxoGen, Inc. (AXGN) Jumps 5.45% on Insider Buying - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Dec 19, 8:18AM CST
AxoGen, Inc. (AXGN) was a big mover last session, as the company saw its shares rise by over 5% on the day.
AXGN: 3.85 (+0.17), AKRX: 36.47 (+0.43)

FDA clears Lannett's generic eye drug
Seeking Alpha - at Seeking Alpha - Thu Dec 18, 12:34PM CST

LCI: 42.29 (+1.79), AKRX: 36.47 (+0.43)

UCB Puts Kremers Back on Block After Scrapping $1.5B Sale
at The Street - Wed Dec 17, 8:50AM CST
Parties agree to tear up the November agreement after a regulatory hiccup.
AKRX: 36.47 (+0.43)

Dr. Reddy's Laboratories (RDY) in Focus: Stock Falls 7.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Dec 17, 8:06AM CST
Dr. Reddy's Laboratories stock fell over 7% last trading session, continuing its recent downtrend
AKRX: 36.47 (+0.43), RDY: 49.58 (-0.10)

3 Companies Growing Faster Than MannKind Corporation
Sean Williams, The Motley Fool - Motley Fool - Wed Dec 17, 6:03AM CST
Source: MannKind. MannKind shareholders have had quite the year. After more than doubling in the first half of the year, shares have since given back all of their gains and sit essentially unchanged. Despite the stalemate, MannKind could be on...
AKRX: 36.47 (+0.43), ALXN: 181.96 (+3.09), ACOR: 39.14 (+0.74), SNY: 46.35 (+0.50), MNKD: 5.68 (+0.18)

Actavis to Appeal Ruling Regarding Namenda IR Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 16, 5:20PM CST
Actavis plc (ACT) announced its decision to file an emergency appeal for an immediate overturn of the lower court ruling that will require the company to continue selling Namenda IR.
IPXL: 31.32 (+0.26), ACT: 254.20 (-1.68), AKRX: 36.47 (+0.43), MYL: 56.97 (+0.39)

Stocks Mixed In Volatile Session; Boeing Boosts Dow
at Investor's Business Daily - Tue Dec 16, 2:04PM CST
Stocks wavered and were mixed heading into the final hour Tuesday. The Dow clung to a 0.2% gain, while the S&P 500 added a fraction and the Nasdaq fell 0.4%. Volume was tracking mildly higher across the board. The Russell 2000 outperformed in the...
AKRX: 36.47 (+0.43), BA: 131.24 (+1.21), BCPC: 66.80 (-1.55), MMS: 54.94 (+0.06)

Great Stocks: Drugmaker Akorn Works On Base
at Investor's Business Daily - Mon Dec 15, 5:33PM CST
Generic-drug maker Akorn is among a few stocks in the Spotlight screen that is working on a base. Even better, the pattern is second stage, which has a better chance of success than a base that forms later in a stock's advance. The potential buy...
AKRX: 36.47 (+0.43)

Insider Trading Alert - AHC, AKRX And CNBKA Traded By Insiders
at The Street - Mon Dec 15, 9:30AM CST
Stocks with insider trader activity include AHC, AKRX and CNBKA
CNBKA: 40.34 (+0.31), AHC: 13.09 (-0.03), AKRX: 36.47 (+0.43)

Why Akorn (AKRX) is Poised to Beat Earnings Estimates Again - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Dec 15, 8:03AM CST
Akorn has seen a nice streak of beating earnings estimates at the previous two reports and might be in a good position to beat earnings at its next report
AKRX: 36.47 (+0.43)

Actavis Likely to Continue Selling Namenda IR Tablets - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 12, 2:20PM CST
Actavis plc (ACT) may face an injunction under which the company will have to continue selling Namenda IR.
IPXL: 31.32 (+0.26), ACT: 254.20 (-1.68), AKRX: 36.47 (+0.43), MYL: 56.97 (+0.39)

Technical Data on Pharma Stocks - Pfizer, Merck, AbbVie, Akorn, and The Medicines
PR Newswire - Fri Dec 12, 8:10AM CST
Investor-Edge has initiated coverage on the following equities: Pfizer Inc. (NYSE: PFE), Merck and Company Inc. (NYSE: MRK), AbbVie Inc. (NYSE: ABBV), Akorn Inc. (NASDAQ: AKRX), and The Medicines Company (NASDAQ: MDCO). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Thursday, December 11, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,596.34, up 0.36% and the NASDAQ Composite closed at 4,708.16, up 0.52%. The S&P 500 finished the session 0.45% higher at 2,035.33. During the trading session, all the ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 806.11, up 0.26%, with the index advancing 8.67% in the previous three months. Register for your complimentary reports on these five stocks at:
MDCO: 27.06 (+0.21), AKRX: 36.47 (+0.43), MRK: 57.46 (+0.25), PFE: 31.42 (-0.03), ABBV: 66.21 (+1.86)

Supernus Faces another Patent Challenge for Oxtellar XR - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 2:20PM CST
Supernus Pharmaceuticals, Inc. (SUPN) received a Para IV notice from TWi Pharma, seeking approval for its generic version of Supernus' Oxtellar XR in the U.S.
ACT: 254.20 (-1.68), AKRX: 36.47 (+0.43), SUPN: 8.52 (+0.15), MYL: 56.97 (+0.39)

Supernus Faces New Patent Challenge for Trokendi XR - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 10, 1:50PM CST
Supernus Pharmaceuticals, Inc. (SUPN) received a Paragraph IV notice from Par, which is looking to get its generic version of Supernus' Trokendi XR approved in the U.S.
ACT: 254.20 (-1.68), AKRX: 36.47 (+0.43), SUPN: 8.52 (+0.15), MYL: 56.97 (+0.39)

Energy Sector Drags On Stocks; Lakeland, Spirit, Akorn Rise
at Investor's Business Daily - Wed Dec 10, 9:28AM CST
Stocks opened in the hole Wednesday, posting quiet losses as energy stocks suffered many of the largest early declines. The Dow Jones industrial average and the S&P 500 each slipped 0.6%. The Nasdaq shed 0.4%. Volume was sharply lower, as the stock...
SAVE: 75.68 (+1.52), AKRX: 36.47 (+0.43), COST: 143.65 (-0.50), LAKE: 8.94 (+0.07), XOM: 93.78 (-0.81), VRA: 20.01 (-0.06), FRAN: 16.27 (-0.09), KKD: 19.85 (-0.04), CVX: 113.47 (-0.48), TOL: 32.74 (+0.36), HOV: 4.02 (unch)

Akorn Rises 3.50% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Dec 09, 5:10PM CST
Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $39.01 to a high of $41.31. Yesterday, the shares gained 3.5%, which took the trading range above the 3-day high of $40.50 on volume of 2.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AKRX: 36.47 (+0.43)

Stocks Snap Back After Morning Downdraft; AutoZone Jumps
at Investor's Business Daily - Tue Dec 09, 3:16PM CST
Major averages recovered early losses Tuesday, an impressive performance considering the carnage in overseas markets overnight. At the close, the Nasdaq turned a 1.4% intraday loss into a 0.5% gain. The S&P 500 also fell more than 1% in the morning...
T: 33.96 (-0.07), BIDU: 230.98 (-2.18), SAVE: 75.68 (+1.52), AAP: 160.23 (-0.96), AZO: 617.43 (-3.87), AKRX: 36.47 (+0.43), ORLY: 193.95 (-1.11), DATA: 88.76 (+0.04), VZ: 47.67 (unch), BABA: 105.95 (+0.43)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Union Pacific Faces $98.8 Million Arbitration Tab

Updated Category News Views 181

A Missed Schedule Promise Got Very Expensive Railroad labor disputes can look like paperwork until the bill lands with a thud. Union Pacific is facing an estimated $98.8 million arbitration payout after a Special Board of Adjustments found that the carrier failed to implement a negotiated scheduling benefit for locomotive engineers. That is not loose change, and it is the...

Continue Reading
Saturn and Tileward Put GPU Memory Back to Work Now

Updated Category News Views 49

GPU memory is the tollbooth nobody notices until the whole AI highway backs up. Saturn Cloud’s new partnership with Tileward goes straight at that constraint: use compressed open-model weights, free memory on hardware already installed, and turn that reclaimed capacity into more tokens that an operator can actually sell. It is not glamorous. It may be one of the more...

Continue Reading
Northgate’s Stanton Opening Puts Community Work First

Updated Category News Views 100

A 55,721-square-foot grocery opening can look like ordinary retail churn until you notice where the money and attention are landing. Northgate González Market’s new Stanton location arrives ahead of Thanksgiving, yes, but the more telling detail is the company’s decision to pair a major store launch with 375 jobs and more than $30,000 directed toward families,...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 48

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 103

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 93

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
Fervo IPO Lawsuit Puts 71% Share Collapse in Focus

Updated Category News Views 61

Fervo’s $27 debut has turned into the sort of wreckage IPO buyers dread: shares were alleged to have closed as low as $7.79 when the complaint was filed. That is more than a 71% fall from the May 13, 2026 offering price, and it puts a hard, ugly number beside the new securities class action against the geothermal power developer. More Than a Bad Quarter Is Being Alleged...

Continue Reading
KidneyVoter Push Turns Patient Frustration Into Clout

Updated Category News Views 313

A ballot registration drive rarely tells the whole story, but it can reveal where the pressure is building. The American Association of Kidney Patients says its 2026 nonpartisan KidneyVoter™ effort, “50 States in 50 Days,” reached constituencies in every state after launching September 14. That does not produce a clean vote total or prove legislators will suddenly...

Continue Reading
University of Phoenix Poll Gets a Useful Reality Check

Updated Category News Views 89

Good Numbers, With the Usual Fine Print Employer approval is the kind of evidence career-focused schools desperately need, and University of Phoenix just put up a pretty loud batch of it. Among managers who directly supervise its graduates, 94% said the university understands employer needs, while 92% said its programs align with workforce demands. Those are stout...

Continue Reading
Classic Chevrolet Gives $1.145M to 13 Local Groups

Updated Category News Views 104

A Thanksgiving Check With Some Real Weight More than a million dollars changing hands before lunch is not the usual holiday fluff, and Classic Chevrolet's planned $1,145,040 donation deserves more than a quick nod. On Tuesday, November 24, at 11 a.m. CST, the Grapevine dealership says it will distribute that sum among 13 nonprofit organizations and charitable programs...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Urged to Review Lawsuit Against Cepton, Inc. (CPTN)

Updated Category News Views 203

Class Action Against Cepton, Inc. Unveiled Recent developments have raised significant concerns for investors of Cepton, Inc. (NASDAQ: CPTN) following revelations of a class action lawsuit. Leading national plaintiffs' law firm Berger Montague has stepped in to help those impacted. The lawsuit focuses on investors who bought or sold Cepton shares during a specified...

Continue Reading
Exploring Uber Technologies: A Strategic Trade Perspective

Updated Category News Views 172

Uber Technologies Inc.'s Current Market Position Recently, ride-sharing giant Uber Technologies, Inc. (NYSE: UBER) experienced a notable increase in its market value. This uplift followed an innovative announcement regarding the capability for riders to book an Avride robotaxi, showcasing the evolution of autonomous mobility solutions. In the past five trading days, UBER...

Continue Reading
Celebrating Diversity: Winners of the Art Limitless Contest

Updated Category News Views 168

Celebrating the Art Limitless Competition Winners In the heart of artistic innovation, BE OPEN has unveiled the winners of the Art Limitless competition, an initiative celebrating inclusivity and diversity in the arts. This remarkable program strives to empower artists with disabilities, showcasing their work while inspiring broader societal awareness. What is Art...

Continue Reading
Certuity Welcomes Constantine Hatzivassiliou as New Partner

Updated Category News Views 246

Certuity Welcomes Constantine Hatzivassiliou as New Partner Certuity, a leading multi-family office dedicated to serving high-net-worth individuals and families, is thrilled to announce the promotion of Managing Director Constantine Hatzivassiliou to Partner. This significant advancement not only reflects Hatzivassiliou's commitment to the firm but also the invaluable...

Continue Reading
Sila Realty Trust, Inc.'s Key Updates on Q3 2024 Earnings

Updated Category News Views 124

Sila Realty Trust, Inc. Announces Upcoming Q3 Earnings Release Sila Realty Trust, Inc. (NYSE: SILA) recently made an announcement regarding its anticipated financial results for the third quarter of 2024. The company will release these earnings on a Tuesday morning, just before the market opens. This timely communication reflects Sila's commitment to transparency and...

Continue Reading